Leptin levels in obese women with and without type 2 diabetes mellitus

Mediators of Inflammation

Volumn 13, Issue 5-6, 2004, Pages 321-325

  Buyukbese, Mehmet Akif ^a   Cetinkaya, Ali ^a   Kocabas, Ramazan ^b   Guven, Aytekin ^a   Tarakcioglu, Mehmet ^b  

^a KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

^b GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Leptin; Obesity; Type 2 diabetes mellitus; Women

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIABETES CONTROL; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; INTERMETHOD COMPARISON; LIPID METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; STATISTICAL SIGNIFICANCE;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CREATININE; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LEPTIN; MIDDLE AGED; OBESITY; TRIGLYCERIDES;

EID: 10944267165     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629350400008828     Document Type: Article

References (43)

1. Vidal H. Obesity and inflammation: the adipocytokines. Ann Endocrinol 2003; 64: S40-S44.
2. Considine RV, Sinha MK, Heiman ML, et al. Serum immunorecative-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-295.
3. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1995; 1: 1311-1314.
4. Chen KW, Boyko EJ, Bergstrom RW, et al. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-year follow-up of initially nondiabetic Japanese-American men. Diabetes Care 1995; 18: 747-753.
5. Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 1998; 22: 1145-1158.
6. Prins JB. Adipose tissue as an endocrine organ. Best Pract Res Clin Endocrinol Metab 2002; 16: 639-651.
7. Correia ML, Haynes WG. Leptin, obesity and cardiovascular disease. Curr Opin Nephrol Hypertens 2004; 13: 215-223.
8. Shamsuzzaman AS, Winnicki M, Wolk R, et al. Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation 2004; 109: 2181-2185.
9. La Cava A, Matarese G, Ebling FM, Hahn BH. Leptin-based immune intervention: current status and future directions. Curr Opin Investig Drugs 2003; 4: 1327-1332.
10. Stejskal D, Adamovska S, Bartek J, Jurakova R, Proskova J. Resistin - concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease (abstract). Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2003; 147: 63-69.
11. Siddiqui AR, Abbas ZA. Leptin and liver disease: facts and presumptions. J Coll Physicians Surg Pak 2004; 14: 122-124.
12. Barbier M, Vidal H, Desreumaux P, et al. Overexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseases. Gastroenterol Clin Biol 2003; 27: 987-991.
13. Sitaraman S, Liu X, Charrier L, et al. Colonic leptin: source of a novel proinflammatory cytokine involved in IBD. FASEB J 2004; 18: 696-698.
14. Tuzun A, Uygun A, Yesilova Z, et al. Leptin levels in the acute stage of ulcerative colitis. J Gastroenterol Hepatol 2004; 19: 429-432.
15. Everhart JE, Pettitt DJ, Bennett PH, Knowler WC. Duration of obesity increases the incidence of NIDDM. Diabetes 1992; 41: 235-240.
16. Radaelli T, Varastehpour A, Catalano P, Hauguel-de Mouzon S. Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes 2003; 52: 2951-2958.
17. Satman I, Yilmaz T, Sengul A, et al. Population based study of diabetes and risk characteristics in Turkey: results of the Turkish diabetes epidemiology study (TURDEP). Diabetes Care 2002; 25: 1551-1556.
18. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26: 5-20.
19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
20. Wei M, Stern HM, Haffner SM. Serum leptin levels in Mexican American and non-Hispanic whites: association with body mass index and cigarette smoking. Ann Epidemiol 1997; 7: 79-80.
21. La Cava A, Alviggi C, Matarese G. Unraveling the multiple roles of leptin in inflammation and autoimmunity. J Mol Med 2004; 82: 4-11.
22. Vettor R, De Pergola G, et al. Gender differences in serum leptin in obese people: relationship with testosterone, body fat distribution and insulin sensitivity. Eur J Clin Invest 1997; 27: 1016-1024.
23. Tasaka Y, Yanagisawa K, Iwamoto Y. Human plasma leptin in obese subjects and diabetics. Endocr J 1997; 44: 671-676.
24. Liuzzi A, Savia G, Tagliaferri M, et al. Serum leptin concentrations in moderate and severe obesity: relationship with clinical, anthropometric and metabolic factors. Int J Obes Relat Metab Disord 1999; 23: 1066-1073.
25. Donahue RP, Prineas RJ, Donahue RD, et al. Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study. Diabetes Care 1999; 22: 1092-1096.
26. Jockenhovel F, Blum WF, Vogel E, et al. Testosteron substitution normalizes elevated serum leptin levels in hypogonadal men. J Clin Endocrinol Metab 1997; 82: 2510-2513.
27. Sweeney G. Leptin signalling. Cell Signal 2002; 14: 655-663.
28. Gomez-Ambrosi J, Salvador J, Paramo JA, et al. Involvement of leptin in the association between percentage of body fat and cardiovascular risk factors. Clin Biochem 2002; 35: 315-320.
29. + channels in pancreatic beta cells. Diabetes 1997; 46: 1087-1093.
30. Bertin E, Rich N, Schneider N, et al. Insulin and body fat distribution have no direct effect on plasma leptin levels in obese Caucasian women with and without type 2 diabetes mellitus. Diabetes Metab 1998; 24: 229-234.
31. Johannsson G, Karlsson C, Lonn L, et al. Serum leptin concentration and insulin sensitivity in men with abdominal obesity. Obes Res 1998; 6: 416-421.
32. Haluzik M, Matoulek M, Svacina S, Hilgertova J, Haas T. The influence of short-term fasting on serum leptin levels, and selected hormonal and metabolic parameters in morbidly obese and lean females. Endocr Res 2001; 27: 251-260.
33. Hodge AM, Boyko EJ, de Courten M, et al. Leptin and other components of the metabolic syndrome in Mauritius - a factor analysis. Int J Obes Relat Metab Disord 2001; 25: 126-131.
34. J Bedir A, Topbas M, Tanyeri F, Alvur M, Arik N. Leptin might be a regulator of serum uric acid concentrations in humans. Jpn Heart J 2003; 44: 527-536.
35. Aguilera A, Bajo MA, Rebollo F, et al. Leptin as a marker of nutrition and cardiovascular risk in peritoneal dialysis patients. Adv Perit Dial 2002; 18: 212-217.
36. Ceddia RB, William WN Jr, Carpinelli AR, Curi R. Modulation of insulin secretion by leptin. Gen Pharmacol 1999; 32: 233-237.
37. Muoio DM, Lynis Dohm G. Peripheric metabolic actions of leptin. Best Pract Res Clin Endocrinol Metab 2002; 16: 653-666.
38. Pelleymounter MA, Cullen MJ, Baker MB, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-543.
39. Rossetti L, Massilon D, Barzilai N, et al. Short time effect of leptin on hepatic gluconeogenesis and invivo insulin action. J Biol Chem 1997; 272: 27758-27763.
40. Clement K, Lahlou N, Ruiz J, et al. Association of poorly controlled diabetes with low serum leptin in morbid obesity. Int J Obes Relat Disord 1997; 21: 556-561.
41. Sivitz WI, Wayson SM, Bayless ML, et al. Leptin and body fat in type 2 diabetes and monodrug therapy. J Clin Endocrinol Metab 2003; 88: 1543-1553.
42. Goren I, Kampfer H, Podda M, Pfeilschifter J, Frank S. Leptin and wound inflammation in diabetic ob/ob mice: differential regulation of neutrophil and macrophage influx and a potential role for scab as a sink for inflammatory cells and mediators. Diabetes 2003; 52: 2821-2832.
43. de Courten M, Zimmet P, Hodge A, et al. Hyperleptinaemia: the missing link in the metabolic syndrome? Diabet Med 1997; 14: 200-208.